Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40
NCT07055425
Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom
View Trial DetailsNCT Number: NCT07047599
This study aims to identify which symptoms or test findings lead men with lower urinary tract symptoms (LUTS) to consider surgical treatment. Male patients who visit the outpatient clinic for LUTS will be asked whether they would consider surgery in the future if their symptoms persist. Along with this, symptom severity scores (IPSS), quality of life scores, and uroflowmetry measurements such as maximum flow rate (Qmax) and post-void residual volume (PVR) will be collected. The goal is to determine which factors are most strongly associated with a desire for surgery. This is an observational, non-interventional study.
Trial opening soon.
Get Notified40 year and older
Male
Observational
This prospective observational study is designed to evaluate which clinical and uroflowmetry parameters are associated with a desire for surgical treatment in male patients presenting with lower urinary tract symptoms (LUTS). Participants will complete the International Prostate Symptom Score (IPSS) questionnaire, including the quality of life (QoL) item, and undergo uroflowmetry testing. Parameters such as maximum urinary flow rate (Qmax), post-void residual urine volume (PVR), and IPSS subdomain scores (e.g., weak stream, nocturia, urgency) will be analyzed. Patients will also be asked a standardized question regarding their surgical preference if their symptoms remain unchanged.
The primary aim is to determine which symptoms or objective findings (e.g., specific IPSS items, reduced Qmax) are most predictive of a preference for surgical intervention. The study will help guide clinical decision-making by identifying symptom patterns or test results that are more likely to prompt patients to consider surgery. No therapeutic intervention will be performed as part of this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (at the outpatient clinic visit)
Total IPSS score will be recorded for each participant at the time of initial outpatient clinic evaluation to assess symptom severity.
Unit of Measure: Points (0 to 35)
Time frame: Baseline (at the outpatient clinic visit)
PVR will be assessed using bladder ultrasound following uroflowmetry at the initial visit.
Unit of Measure: Milliliters (mL)
Time frame: Baseline (at the outpatient clinic visit)
Qmax (in mL/sec) will be measured during the initial outpatient visit using non-invasive uroflowmetry.
Unit of Measure: Milliliters per second (mL/sec)
Time frame: Baseline (at the outpatient clinic visit)
Patients will be asked: "Would you consider surgical treatment if your symptoms remain unchanged in the future?" Response options are Yes/No
Contact information is provided by the study sponsor or research team.
Marmara University
Other
Assessment of Clinical and Uroflowmetry Parameters as Predictors of Surgical Preference in Male Patients With Lower Urinary Tract Symptoms: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07055425
Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom
View Trial DetailsNCT06989515
Anejaculation, Benign Prostate Obstruction (BPO)
View Trial DetailsNCT07416981
Benign Prostatic Hyperplasia, Bladder Outlet Obstruction
View Trial DetailsNCT07627178
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction
Tanta, Gharbia Governorate, Egypt
View Trial Details